Title | Author(s) | Issue date | ???itemlist.??? |
HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy | Fountzilas, G.; Valavanis, C.; Kotoula, V.; Eleftheraki, A. G.; Kalogeras, K. T.; Tzaida, O.; Batistatou, A.; Kronenwett, R.; Wirtz, R. M.; Bobos, M.; Timotheadou, E.; Soupos, N.; Pentheroudakis, G.; Gogas, H.; Vlachodimitropoulos, D.; Polychronidou, G.; Aravantinos, G.; Koutras, A.; Christodoulou, C.; Pectasides, D.; Arapantoni, P. | 24-Nov-2015 | - |
Immunohistochemical Profiling of Signalling Pathways in Cancer of Unknown Primary (CUP) | Pentheroudakis, G.; Petrakis, D.; Goussia, A.; Siozopoulou, V.; Bobos, M.; Fountzilas, G.; Cervantes, A.; Malamou-Mitsi, V.; Ciuleanu, T.; Pavlidis, N. | 24-Nov-2015 | - |
Induction Chemotherapy with Docetaxel and Cisplatin Followed by Concomitant Chemoradiotherapy in Patients with Inoperable Non-nasopharyngeal Carcinoma of the Head and Neck | Fountzilas, G.; Bamias, A.; Kalogera-Fountzila, A.; Karayannopoulou, G.; Bobos, M.; Athanassiou, E.; Kalogeras, K. T.; Tolis, C.; Tsekeris, P.; Papakostas, P.; Vamvouka, C.; Zaramboukas, T.; Kosmidis, P.; Zamboglou, N.; Misailidou, D. | 24-Nov-2015 | - |
Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluation | Fountzilas, G.; Kourea, H. P.; Bobos, M.; Televantou, D.; Kotoula, V.; Papadimitriou, C.; Papazisis, K. T.; Timotheadou, E.; Efstratiou, I.; Koutras, A.; Pentheroudakis, G.; Christodoulou, C.; Aravantinos, G.; Miliaras, D.; Petraki, K.; Papandreou, C. N.; Papakostas, P.; Bafaloukos, D.; Repana, D.; Razis, E.; Pectasides, D.; Dimopoulos, A. M. | 24-Nov-2015 | - |
A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer | Fountzilas, G.; Fragkoulidi, A.; Kalogera-Fountzila, A.; Nikolaidou, M.; Bobos, M.; Calderaro, J.; Andreiuolo, F.; Marselos, M. | 24-Nov-2015 | - |
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial | Gogas, H.; Dafni, U.; Karina, M.; Papadimitriou, C.; Batistatou, A.; Bobos, M.; Kalofonos, H. P.; Eleftheraki, A. G.; Timotheadou, E.; Bafaloukos, D.; Christodoulou, C.; Markopoulos, C.; Briasoulis, E.; Papakostas, P.; Samantas, E.; Kosmidis, P.; Stathopoulos, G. P.; Karanikiotis, C.; Pectasides, D.; Dimopoulos, M. A.; Fountzilas, G. | 24-Nov-2015 | - |
Potential value of PTEN in predicting cetuximab response in colorectal cancer: an exploratory study | Razis, E.; Briasoulis, E.; Vrettou, E.; Skarlos, D. V.; Papamichael, D.; Kostopoulos, I.; Samantas, E.; Xanthakis, I.; Bobos, M.; Galanidi, E.; Bai, M.; Gikonti, I.; Koukouma, A.; Kafiri, G.; Papakostas, P.; Kalogeras, K. T.; Kosmidis, P.; Fountzilas, G. | 24-Nov-2015 | - |
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study | Fostira, F.; Tsitlaidou, M.; Papadimitriou, C.; Pertesi, M.; Timotheadou, E.; Stavropoulou, A. V.; Glentis, S.; Bournakis, E.; Bobos, M.; Pectasides, D.; Papakostas, P.; Pentheroudakis, G.; Gogas, H.; Skarlos, P.; Samantas, E.; Bafaloukos, D.; Kosmidis, P. A.; Koutras, A.; Yannoukakos, D.; Konstantopoulou, I.; Fountzilas, G. | 24-Nov-2015 | - |
Prognostic utility of beta-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study | Pentheroudakis, G.; Batistatou, A.; Kalogeras, K. T.; Kronenwett, R.; Wirtz, R. M.; Bournakis, E.; Eleftheraki, A. G.; Pectasides, D.; Bobos, M.; Papaspirou, I.; Kamina, S.; Gogas, H.; Koutras, A. K.; Pavlidis, N.; Fountzilas, G. | 24-Nov-2015 | - |
A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer | Bamias, A.; Karina, M.; Papakostas, P.; Kostopoulos, I.; Bobos, M.; Vourli, G.; Samantas, E.; Christodoulou, Ch; Pentheroudakis, G.; Pectasides, D.; Dimopoulos, M. A.; Fountzilas, G. | 24-Nov-2015 | - |
Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy | Kostopoulos, I.; Karavasilis, V.; Karina, M.; Bobos, M.; Xiros, N.; Pentheroudakis, G.; Kafiri, G.; Papakostas, P.; Vrettou, E.; Fountzilas, G. | 24-Nov-2015 | - |
Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation | Christodoulou, C.; Kostopoulos, I.; Kalofonos, H. P.; Lianos, E.; Bobos, M.; Briasoulis, E.; Gogas, H.; Razis, E.; Skarlos, D. V.; Fountzilas, G. | 24-Nov-2015 | - |
Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial | Skarlos, P.; Christodoulou, C.; Kalogeras, K. T.; Eleftheraki, A. G.; Bobos, M.; Batistatou, A.; Valavanis, C.; Tzaida, O.; Timotheadou, E.; Kronenwett, R.; Wirtz, R. M.; Kostopoulos, I.; Televantou, D.; Koutselini, E.; Papaspirou, I.; Papadimitriou, C. A.; Pectasides, D.; Gogas, H.; Aravantinos, G.; Pavlidis, N.; Arapantoni, P.; Skarlos, D. V.; Fountzilas, G. | 24-Nov-2015 | - |